
A New Frontier: Microdosing & Low-Dosing Psychedelics for Cluster Headaches and Neurological Disorders
Discover the transformative potential of low-dose psychedelics in addressing some of the world’s most debilitating headache disorders. Join a panel of experts and advocates for a grounded, evidence-based look at how psilocybin, DMT, and other psychedelic tools are reshaping care for cluster headaches and chronic pain.
Inside This Conversation
Understanding the “Suicide Headache”
Explore the clinical profile of cluster headaches—the sudden onset, intense pain, and hallmark symptoms like eye tearing and restlessness that set them apart from migraines.
The Power of Citizen Science
Learn how Clusterbusters and a community of dedicated “psychedelic outlaws” pioneered their own research and dosing protocols when traditional medicine left patients behind.
Breaking the Cycle with “Busting”
Discover the pulse regimen, a strategic microdosing schedule that helps stop cluster cycles and supports long-term remission.
DMT as an Acute Intervention
Hear emerging evidence showing how inhaled DMT may provide rapid relief—sometimes in under 30 seconds—offering a critical tool for sudden attacks.
Healing Beyond the Physical
Experience first-hand stories of how psychedelic medicine not only eased physical pain but also addressed the deep emotional and psychological impact of chronic headache disorders.
Navigating the Future of Research
Get an update on clinical trials, the challenges of studying psychedelics, and how citizen-led surveys are driving the next wave of treatment breakthroughs.
Speakers & Hosts

Kevin Lenaburg
Policy Director at Clusterbusters

Dr. Evan Lewis
MD
Neurologist, North Toronto Neurology; Assistant Professor, University of Toronto; Medical Advisor at Microdosing Collective

Joe McKay
First Responder Now Advocating for Cluster Headache

Stephanie Karzon Abrams
Founder of Beyond Consulting
Research Director at Microdosing Collective
MSc Clinical Neuropharmacologist


